Measurement of airway hyperresponsiveness: New considerations

Thorax

Volumn 53, Issue 5, 1998, Pages 419-424

  Lötvall, Jan ^b   Inman, Mark ^b   O'Byrne, Paul ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; DIAGNOSTIC APPROACH ROUTE; FORCED EXPIRATORY VOLUME; PRIORITY JOURNAL; PROVOCATION; REVIEW;

EID: 0031840752     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.5.419     Document Type: Review

References (64)

1. Curry JJ. The action of histamine on the respiratory tract in normal and asthmatic subjects. J Clin Invest 1946;25:785 91.
2. Sterk PJ. Bronchial hyperresponsiveness: definition and terminology. Pediatr Allergy Immunol 1996;7(Suppl 9):7-9.
3. Cockcroft DW. Airway responsiveness. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, eds. Asthma. Philadelphia: Lippincott-Raven, 1997: 1253-66.
4. Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 1977;7:503-13.
5. Murray AB, Ferguson AC, Morrison B. Airway responsiveness to histamine as a test for overall severity of asthma in children. J Allergy Clin Immunol 1981;68:119-24.
6. Boushey HA, Holtzman MJ, Sheller JR, et al. Bronchial hyperreactivity. Am Rev Respir Dis 1980;121:389-413.
7. Cartier A, Thomson NC, Frith PA, et al. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 1982;70:170-7.
8. Carroll N, Elliot J, James A. The structure of the large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993;147:405-10.
9. Jeffery PK, Godfrey RW, Adelroth E, et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-9.
10. Lötval J, Lernen RJ, Hui KP, et al. Airflow obstruction after substance P aerosol: contribution of airway and pulmonary edema. J Appl Physiol 1990;69:1473-8.
11. Persson CG. Role of plasma exudation in asthmatic airways. Lancet 1986;ii:1126-9.
12. Tokuyama K, Lötval J, Barnes PJ, et al. Mechanisms of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage. Am Rev Respir Dis 1991;143:1345-9.
13. Chung KF, Rogers DF, Barnes PJ, et al. The role of increased airway microvascular permeability and plasma exudation in asthma. Eur Respir J 1990;3:329-37.
14. Hogg JC, Pare PD, Moreno R. The effect of submucosal edema on airways resistance. Am Rev Respir Dis 1987;135: s54-6.
15. Jeffery PK, Wardlaw AJ, Nelson FC, et al. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140: 1745-53.
16. Beasley R, Roche WR, Roberts JA, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
17. Flavahan NA, Aarhus LL, Rimele TJ, et al. Respiratory epithelium inhibits bronchial smooth muscle tone. J Appl Physiol 1985;58:834-8.
18. Stuart-Smith K, Vanhoutte PM. Arachadonic acid evokes epithelium-dependent relaxations in canine airways. J Appl Physiol 1988;65:2170-80.
19. Ullman A, Ciabattoni G, Löfdahl CG, et al. Epithelium-derived PGE2 inhibits the contractile response to cholinergic stimulation in isolated ferret trachea. Pulmonol Pharmacol 1990;3:155-60.
20. Lundgren R, Söderberg M, Hörstedt P, et al. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1988;1:883-9.
21. Woolley KL, Adelroth E, Woolley MJ, et al. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma. Eur Respir J 1994;7: 1576-84.
22. Aalbers R, Kauffman HF, Vrugt B, et al. Allergen-induced recruitment of inflammatory cells in lavage 3 and 24 h after challenge in allergic asthmatic lungs. Chest 1993;103:1178-84.
23. Brusasco V, Crimi E, Gianiorio P, et al. Allergen-induced increase in airway responsiveness and inflammation in mild asthma. J Appl Physiol 1990;69:2209-14.
24. Pin I, Freitag AP, O'Byrne PM, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic-responses. Am Rev Respir Dis 1992;145:1265-9.
25. Palmqvist M, Petterson K, Sjöstrand M, et al. Variability of lung function during repeated low-dose allergen exposure in mild asthmatics. Am J Respir Crit Care Med 1997;155: A883.
26. Sulakvelidze I, Inman MD, Rerecich T, et al. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low dose allergen challenge in atopic asthmatics. Eur Respir J 1998 (in press).
27. Djukanovic R, Feather I, Walls A, et al. Effect of natural allergen exposure during the grass pollen season on inflammatory cells and asthma symptoms. Thorax 1996;51:575-81.
28. Platts-Mills TA, Tovey ER, Mitchell EB, et al. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982;ii:675-8.
29. Peroni DG, Boner AL, Vallone G, et al. Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med 1994;149:1442-6.
30. van Velzen E, van den Bos J-W, Benckhuijsen JAW, et al. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996;51:582-4.
31. Brand PRL, Postma DS, Kerstjens HAM, et al. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variations in patients with obstructive lung disease. Am Rev Respir Dis 1991;143:916-21.
32. Ryan G, Latimer KM, Dolovich J, et al. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982;37:423-9.
33. Josephs LK, Gregg I, Mullee MA, et al. Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma. A longitudinal study. Am Rev Respir Dis 1989;140:350-7.
34. Gibson PG, Wong BJ, Hepperle MJ, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 1992;22:525-32.
35. Altounyan REC. Changes in histamine and atropine responsiveness as a guide to diagnosis and evaluation of therapy in obstructive airway disease. In: Pepys J, Frankland AW, eds. Disodium cromoglycate in allergic airways disease. Edinburgh and London: Butterworths, 1970: 47.
36. Boulet LP, Cartier A, Thompson NC, et al. Asthma and increases in non-allergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol 1983;71: 399-406.
37. Sotomayor H, Badier M, Vervloet D, et al. Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen. Reversal by corticosteroids. Am Rev Respir Dis 1984;130:56-8.
38. Löwhagen O, Rak S. Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season. J Allergy Clin Immunol 1985;75:460-7.
39. Gibson PG, Manning PJ, O'Byrne PM, et al. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils and their progenitors. Am Rev Respir Dis 1991;143:331-5.
40. Cockcroft DW, Murdock KY. Changes in bronchial responsiveness to histamine at intervals after allergen challenge. Thorax 1987;42:302-8.
41. Violante B, Pellegrino R, Crimi E, et al. Increase in airway responsiveness and effect of deep inhalation on airway caliber in allergen-induced asthma. Relationship to the late-phase response. Am Rev Respir Dis 1992;146:127-31.
42. Inman MD, Hamilton AL, Kerstjens HAM, et al. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs. J Allergy Clin Immunol 1998 (in press).
43. Pedersen B, Dahl R, Larsen BB, et al. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy 1993;48: 377-82.
44. Gratziou C, Carroll M, Montefort S, et al. Inflammatory and T-cell profile of asthmatic airways 6 hours after local allergen provocation. Am J Respir Crit Care Med 1996;153: 515-20.
45. Woolley KL, Adelroth E, Woolley MJ, et al. Effects of allergen challenge on eosinophils, eosinophil cationic protein and granulocyte-macrophage colony stimulating factor in mild asthma. Am J Respir Crit Care Med 1995;151:1915 24.
46. Fahy JV, Liu J, Wong H, et al. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 1994;93:1031-9.
47. Wong BJ, Dolovich J, Ramsdale EH, et al. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. Am Rev Respir Dis 1992;146: 1156-60.
48. Ihre E, Zetterström O. Increase in non-specific bronchial responsiveness after repeated inhalation of low doses of allergen. Clin Exp Allergy 1993;23:298-305.
49. O'Byrne PM, Ramsdale EH, Hargreave FE. Isocapnic hyperventilation for measuring airway hyperresponsiveness in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:1444-5.
50. Holgate ST, Mann JS, Cushley MJ. Adenosine as a bronchoconstrictor mediator in asthma and its antagonism by methylxanthines. J Allergy Clin Immunol 1984;74: 302-6.
51. Mann JS, Holgate ST, Renwick AG, et al. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 1986;61:1667-76.
52. Boulet LP, Latimer KM, Roberts RS, et al. The effect of atropine on allergen-induced increases in bronchial responsiveness to histamine. Am Rev Respir Dis 1984;430: 368-72.
53. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987;79:734-40.
54. Cockcroft DW, Murdock KY, Gore BP, et al. Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholine. J Allergy Clin Immunol 1989;83:913-20.
55. Taylor G, Walker J, Twentyman OP, et al. Protection against allergen-induced asthma by salmeterol. Clin Allergy 1990; 336:1338-42.
56. Twentyman OP, Finnerty J, Harris A, et al. Protection against allergen-induced asthma by salmeterol. Lancet 1990;336:1338-42.
57. Hui KP, Taylor IK, Taylor GW, et al. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 1991;46:184-9.
58. Taylor IK, O'Shaughnessy KM, Fuller RW, et al. Effect of cysteinyl leukotriene receptor antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991;337:690-4.
59. Cockcroft DW, McParland CP, O'Byrne PM, et al. Beclamethasone given after the early asthmatic response inhibits the late response and the increased methacholine reponsiveness. J Allergy Clin Immunol 1993;91:1163-8.
60. Crimi E, Violante B, Pellegrino R, et al. Effect of multiple doses of nedocromil sodium given after allergen inhalation in asthma. J Allergy Clin Immunol 1993;92:777-83.
61. Freitag A, Watson RM, Matsos G, et al. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. Thorax 1993;48:594-8.
62. Hamilton AL, Watson RM, Wylie G, et al. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005. Thorax 1997;52:348-354.
63. Manning PJ, Stevens WH, Cockcroft DW, et al. The role of thromboxane in allergen-induced asthmatic responses. Eur Respir J 1991;4:667-72.
64. Inman MD, Watson R, Cockcroft DW, et al. Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol 1995;95:119-5.